AAAAAA

   
Results: 1-9 |
Results: 9
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques
Authors: Rosenwirth, B Kuhn, EM Heeney, JL Hurpin, C Tartaglia, J Bonnet, MC Moingeon, P Erdile, L
Citation: B. Rosenwirth et al., Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques, VACCINE, 19(13-14), 2001, pp. 1661-1670
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIVF359)
Authors: Holterman, L Dubbes, R Mullins, J Learn, G Niphuis, H Koornstra, W Koopman, G Kuhn, EM Wade-Evans, A Rosenwirth, B Haaijman, J Heeney, J
Citation: L. Holterman et al., Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIVF359), J VIROLOGY, 75(19), 2001, pp. 9328-9338
Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue
Authors: Ensser, A Glykofrydes, D Niphuis, H Kuhn, EM Rosenwirth, B Heeney, JL Niedobitek, G Muller-Fleckenstein, I Fleckenstein, B
Citation: A. Ensser et al., Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue, J EXP MED, 193(5), 2001, pp. 637-642
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens
Authors: Heeney, JL Koopman, G Rosenwirth, B Bogers, W van Dijk, J Nieuwenhuis, I Niphuis, H ten Haaft, P Hanke, T Rhodes, G Berglund, P Burny, A Bex, F Sutter, G Liljestrom, P
Citation: Jl. Heeney et al., A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens, J MED PRIM, 29(3-4), 2000, pp. 268-273
Antiretroviral therapy during primary immunodeficiency virus infection caninduce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
Authors: Rosenwirth, B ten Haaft, P Bogers, WMJM Nieuwenhuis, IG Niphuis, H Kuhn, EM Bischofberger, N Heeney, JL Uberla, K
Citation: B. Rosenwirth et al., Antiretroviral therapy during primary immunodeficiency virus infection caninduce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques, J VIROLOGY, 74(4), 2000, pp. 1704-1711
Herpesvirus Saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity
Authors: Glykofrydes, D Niphuis, H Kuhn, EM Rosenwirth, B Heeney, JL Bruder, J Niedobitek, G Muller-Fleckenstein, I Fleckenstein, B Ensser, A
Citation: D. Glykofrydes et al., Herpesvirus Saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity, J VIROLOGY, 74(24), 2000, pp. 11919-11927
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates
Authors: Heeney, J Akerblom, L Barnett, S Bogers, W Davis, D Fuller, D Koopman, G Lehner, T Mooij, P Morein, B Morghen, CD Rosenwirth, B Verschoor, E Wagner, R Wolf, H
Citation: J. Heeney et al., HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates, IMMUNOL LET, 66(1-3), 1999, pp. 189-195
An anti-HIV strategy combining chemotherapy and therapeutic vaccination
Authors: Rosenwirth, B Bogers, WMJM Nieuwenhuis, IG Ten Haaft, P Niphuis, H Kuhn, EM Bischofberger, N Erfle, V Sutter, G Berglund, P Liljestrom, P Uberla, K Heeney, JL
Citation: B. Rosenwirth et al., An anti-HIV strategy combining chemotherapy and therapeutic vaccination, J MED PRIM, 28(4-5), 1999, pp. 195-205
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus
Authors: Verschoor, EJ Davis, D van Gils, M Koopman, G Mooij, P Oostermeijer, H Ten Haaft, P Verstrepen, B Rosenwirth, B Morein, B Barnett, SW Heeney, JL
Citation: Ej. Verschoor et al., Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus, J MED PRIM, 28(4-5), 1999, pp. 224-232
Risultati: 1-9 |